Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of probable early Alzheimer's disease~* stable dose of acetylcholinesterase inhibitor~* community dwelling~* stable medical condition~Exclusion Criteria:~* unstable and significant medical conditions~* recurrent major psychiatric disorder~* treatment with memantine

- Gender: ALL
- Minimum Age: 56 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).